Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: puborectalis who wrote (1231966)	5/22/2020 8:54:34 AM
From: locogringo	1 Recommendation Recommended By Mick Mørmøny Read Replies (1) \| Respond to of 1583406

FAKE crap. Go tell it to Amy Klobuchar: Klobuchar Admits Hydroxychloroquine Saved Her Husband’s Life...

To: puborectalis who wrote (1231966)	5/22/2020 9:01:10 AM
From: rxbond	Respond to of 1583406

Focus on this virus that we are trying to kill. What a joke you guys are. Racism!! "If you have a problem figuring out whether you're for me or Trump, then you ain't black" .@JoeBiden: "If you have a problem figuring out whether you're for me or Trump, then you ain't black." @cthagod: "It don't have nothing to do with Trump, it has to do with the fact -- I want something for my community." @breakfastclubam pic.twitter.com/endvWnOIV2 — America Rising (@AmericaRising) May 22, 2020

To: puborectalis who wrote (1231966)	5/22/2020 9:26:13 AM
From: Sdgla	2 Recommendations Recommended By locogringo TideGlider Respond to of 1583406

The proof is in the numbers. You will not respond to facts... that’s just the dem way. Slander then run and hide. Thousands of Doctors: Yes, Hydroxychloroquine Works Against Wuhan Coronavirus Katie Pavlich \| @KatiePavlich \| Posted: Apr 06, 2020 2:30 PM Share Tweet Source: AP Photo/John Locher Over the past three weeks, there's been debate over whether hydroxychloroquine, a drug used for decades to treat malaria, can help ease the symptoms of Wuhan coronavirus. During White House press briefings, reporters have done their best to shoot down the possibility. But doctors around the country and the world are using it and seeing positive results. First, in Los Angeles: Dr. Anthony Cardillo said he has seen very promising results when prescribing hydroxychloroquine in combination with zinc for the most severely-ill COVID-19 patients. "Every patient I've prescribed it to has been very, very ill and within 8 to 12 hours, they were basically symptom-free," Cardillo told Eyewitness News. "So clinically I am seeing a resolution." Cardillo is the CEO of Mend Urgent Care, which has locations in Sherman Oaks, Van Nuys and Burbank. He said he has found it only works if combined with zinc. The drug, he said, opens a channel for the zinc to enter the cell and block virus replication. "We have to be cautious and mindful that we don't prescribe it for patients who have COVID who are well," Cardillo said. "It should be reserved for people who are really sick, in the hospital or at home very sick, who need that medication. Otherwise we're going to blow through our supply for patients that take it regularly for other disease processes." New York: Dr. Mohammud Alam, an infectious disease specialist affiliated with Plainview Hospital, said 81 percent of infected covid patients he treated at three Long Island nursing homes recovered from the contagion. “In this crisis, I realized I had to do something,” Alam said. ”I realized if this was my dad, what would I do? And I would do anything I could to help.” Alam said he decided he could not apply the touted combination of the antimalarial hydroxychloroquine and antibiotic azithromycin because the side effects could be potentially fatal for his high-risk patients, many of whom had underlying heart issues. So instead, Alam replaced azithromycin with another decades-old antibiotic that doesn’t pose any known risks to the heart. New Jersey: Dr. Stephen Smith, founder of The Smith Center for Infectious Diseases and Urban Health, said on “The Ingraham Angle” on Wednesday night that he is optimistic about the use of antimalarial medications and antibiotics to treat COVID-19 patients, calling it “a game-changer.” Smith, who is treating 72 COVID-19 patients, said that he has been treating "everybody with hydroxychloroquine and azithromycin [an antibiotic]. We’ve been doing so for a while.” He pointed out that not a single COVID-19 patient of his that has been on the hydroxychloroquine and azithromycin regimen for five days or more has had to be intubated. Around the world: An international poll of thousands of doctors rated the Trump-touted anti-malaria drug hydroxychloroquine the best treatment for the novel coronavirus. Of the 6,227 physicians surveyed in 30 countries, 37 percent rated hydroxychloroquine the “most effective therapy” for combating the potentially deadly illness, according to the results released Thursday. The survey, conducted by the global health care polling company Sermo, also found that 23 percent of medical professionals had prescribed the drug in the US — far less than other countries. "Outside the US, hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the US it was most commonly used for high risk diagnosed patients,” the survey found. The medicine was most widely used in Spain, where 72 percent of physicians said they had prescribed it. It's working, which is why President Trump is touting its use.

To: puborectalis who wrote (1231966)	5/22/2020 9:39:36 AM
From: locogringo	2 Recommendations Recommended By Mick Mørmøny Thomas M. Respond to of 1583406

The Lancet speaks (reports) out of both sides of it's fake mouth: Chloroquine or hydroxychloroquine for prophylaxis of COVID ... thelancet.com. The Lancet also knocks the W.H.O..........do you agree with them on on that? Of course not! The Lancet has taken a political stand on several important medical and non-medical issues. Recent examples include criticism of the World Health Organization (WHO) en.wikipedia.org The Lancet knocks Trump....do you agree with them on that? OF COURSE YOU DO! BLAH....BLAH....BLAH.....HYPOCRITES

To: puborectalis who wrote (1231966)	5/22/2020 9:53:49 AM
From: locogringo	1 Recommendation Recommended By Mick Mørmøny Respond to of 1583406

R-A-C-I-S-T! Democrat Joe Biden to Black Americans: Either Vote for Me or ‘You Ain’t Black’

To: puborectalis who wrote (1231966)	6/4/2020 7:31:32 PM
From: FJB	1 Recommendation Recommended By Mick Mørmøny Read Replies (1) \| Respond to of 1583406

OH LOOK. I FOUND ONE OF THE RETARDS THAT FELL FOR THIS HOAX. LANCET PUBLISHED HOAX, SCAM STUDY. Authors retract influential study linking hydroxychloroquine to mortality risk for coronavirus patients By David Hogberg June 4, 2020 - 3:45 PM 00:0002:18 Three authors have retracted an influential study on the risks of hydroxychloroquineas a treatment for the COVID-19 virus. The article, published in the journal Lancet, had found that hydroxychloroquine, an anti-malaria drug, increased mortality and heart problems in patients suffering from the coronavirus. It had been cited in criticizing President Trump's promotion of the drug as a remedy for the disease. But questions arose about how one of the authors, Dr. Sapan Desai, and the company he owns, Surgisphere, were able to compile a massive dataset with very few employees and in a short amount of time. The authors said they are retracting the article, as they “can no longer vouch for the veracity of the primary data sources" because Surgisphere would not provide the dataset for an independent review. The three authors retracting the story are Dr. Mandeep Mehra, medical director of the Brigham Heart and Vascular Center, Dr. Amit Patel, director of clinical regenerative medicine and tissue engineering at the University of Utah, and Dr. Frank Ruschitzka, chairman of the cardiology department at University Hospital Zurich. Surgisphere was founded in 2008 by vascular surgeon Sapan Desai, who is also the co-author of the Lancet study. Desai claims Surgisphere has 11 employees. The company's marketing executive appears to be a pornographic model and event hostess, while its science editor appears to be a science fiction author. Influential hydroxychloroquine study used suspect data from company run by pornographic model and sci-fi author Peter Ellis, the chief data scientist of Nous Group, an international management consultancy that does data integration projects for government departments, toldthe Guardian that Surgisphere "was almost certainly a scam ... There’s no evidence online of [Surgisphere] having any analytical software earlier than a year ago. It takes months to get people to even look into joining these databases, it involves network review boards, security people, and management. It just doesn’t happen with a sign-up form and a conversation.” Hydroxychloroquine became a household name when Trump touted it as a possible treatment for COVID-19. He recently said that he'd completed a preventative hydroxychloroquine regime. The Lancet study prompted the World Health Organization to cease its trialsof the drug and France to ban its use. Last week, Dr. Anthony Fauci, one of the lead members of the Trump administration's coronavirus task force, declared hydroxychloroquine to be ineffective in treating COVID-19